
Introducing Medically Supervised Weight Loss with Semaglutide!
Are you struggling with your weight? The experts at St Louis Skin Solutions are excited to introduce Semaglutide for long-term weight loss. We are happy to offer the newest drug in the weight loss medication arena- Semaglutide with the brand name Wegovy™. In June of 2021, the FDA approved Semaglutide injections for chronic weight management in adults. This was the first approval of a new weight loss drug since 2014. Are you a candidate for Semaglutide? Let the experts at St. Louis Skin Solutions work with you to kickstart your weight loss journey. This drug, originally used for the treatment of Type II diabetes and sold under the brand name Ozempic, is injected underneath the skin once a week using a small needle that causes little to no pain.
Wegovy™ (semaglutide) is a game changer in the obesity medication market. The average weight loss in study participants resulted in a 15% reduction in their body weight. Long-duration trials of 60-plus weeks showed that the weight loss was sustained while continuing the medication. When the medication was discontinued, some weight was regained, however, there was still a 5% weight loss from baseline.